Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

RXRX

+ Watchlist+ Portfolio

Recursion Pharmaceuticals, Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.72
52-Week Range
$2.50 – $5.24
Market Cap
$1.76B
P/E (TTM)
—
EPS (TTM)
-0.86
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.75
PEG Ratio
—
Return on Equity
-48.72%
Return on Assets
-23.89%
Gross Margin
0.00%
Operating Margin
-734.17%
Profit Margin
0.00%
Current Ratio
5.01
Debt/Equity
0.08
Total Debt
$74.70M
Free Cash Flow
$-203.12M
Revenue Growth
258.50%
Earnings Growth
—
Enterprise Value
$1.29B

Market Snapshot

About

Recursion Pharmaceuticals, Inc. is a biotechnology company pioneering the use of artificial intelligence and machine learning in drug discovery. The company operates a massive biological and chemical dataset to identify new therapeutic candidates across multiple disease areas. Recursion combines experimental biology, automation, and computational power to industrialize drug discovery at scale.